Mercator Medical S.A. (MRC) — Capital Reinvestment Ratio
Latest as of September 2025:
0.25x
Mercator Medical S.A. (MRC) has a Capital Reinvestment Ratio of 0.25x as of September 2025, meaning it reinvests 0% of its operating cash flow (zł46.48 Million) in capital expenditures (zł11.67 Million). See MRC FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.25x
Capex / Operating Cash Flow
Operating Cash Flow
zł46.48 Million
PLN
Capital Expenditures
zł11.67 Million
PLN
Data as of
Sep 2025
Most recent filing
Mercator Medical S.A. Capital Reinvestment Ratio (2012–2022)
This chart tracks Mercator Medical S.A.'s Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for Mercator Medical S.A. (2012–2022)
Year-by-year Capital Reinvestment Ratio for Mercator Medical S.A. from 2012 to 2022. For live market cap and broader valuation context, see market value of Mercator Medical S.A..
| Year | Reinvestment Ratio | Operating CF (PLN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 2.69x | zł40.79 Million | zł109.65 Million | ▲ +665.0% |
| 2021 | 0.35x | zł503.00 Million | zł176.75 Million | ▲ +1515.7% |
| 2020 | 0.02x | zł712.47 Million | zł15.49 Million | ▼ -94.6% |
| 2019 | 0.40x | zł38.53 Million | zł15.57 Million | ▼ -87.0% |
| 2017 | 3.10x | zł23.67 Million | zł73.41 Million | ▲ +156.3% |
| 2016 | 1.21x | zł16.61 Million | zł20.10 Million | ▼ -16.5% |
| 2015 | 1.45x | zł7.88 Million | zł11.41 Million | ▼ -30.6% |
| 2014 | 2.09x | zł12.56 Million | zł26.24 Million | ▼ -49.7% |
| 2013 | 4.16x | zł1.92 Million | zł7.99 Million | ▲ +643.6% |
| 2012 | 0.56x | zł7.57 Million | zł4.23 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow